-
Something wrong with this record ?
Differential hemodynamic effects of exercise and volume expansion in people with and without heart failure
MJ. Andersen, TP. Olson, V. Melenovsky, GC. Kane, BA. Borlaug,
Language English Country United States
Document type Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
NLK
Free Medical Journals
from 2008 to 1 year ago
Open Access Digital Library
from 2008-05-01
- MeSH
- Sodium Chloride administration & dosage diagnostic use MeSH
- Exercise physiology MeSH
- Hemodynamics physiology MeSH
- Infusions, Intravenous MeSH
- Middle Aged MeSH
- Humans MeSH
- Follow-Up Studies MeSH
- Prospective Studies MeSH
- Aged MeSH
- Cardiac Catheterization MeSH
- Heart Failure physiopathology therapy MeSH
- Exercise Therapy methods MeSH
- Treatment Outcome MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Randomized Controlled Trial MeSH
BACKGROUND: Invasive hemodynamic exercise testing is commonly used in the evaluation of patients with suspected heart failure with preserved ejection fraction (HFpEF) or pulmonary hypertension. Saline loading has been suggested as an alternative provocative maneuver, but the hemodynamic changes induced by the 2 stresses have not been compared. METHODS AND RESULTS: Twenty-six subjects (aged, 67±10 years; n=14 HFpEF; n=12 control) underwent right heart catheterization at rest, during supine exercise, and with acute saline loading in a prospective study. Exercise and saline each increased cardiac output and pressures in the right atrium, pulmonary artery, and pulmonary capillary wedge positions. Changes in heart rate, blood pressure, rate-pressure product, and cardiac output were greater with exercise compared with saline. In controls subjects, right atrial pressure, pulmonary arterial pressure, and pulmonary capillary wedge pressure increased similarly with saline and exercise, whereas in HFpEF subjects, exercise led to ≈2-fold greater increases in right atrial pressure (10±4 versus 6±3 mm Hg; P=0.02), pulmonary arterial pressure (22±8 versus 11±4 mm Hg; P=0.0001), and pulmonary capillary wedge pressure (18±5 versus 10±4 mm Hg; P<0.0001) compared with saline. Systolic reserve assessed by stroke work and cardiac power output was lower in HFpEF subjects with both exercise and saline. Systemic and pulmonary arterial compliances were enhanced with saline but reduced with exercise. CONCLUSIONS: Exercise elicits greater pulmonary capillary wedge pressure elevation compared with saline in HFpEF but not controls, suggesting that hemodynamic stresses beyond passive stiffness and increased venous return explain the development of pulmonary venous hypertension in HFpEF. Exercise testing is more sensitive than saline loading to detect hemodynamic derangements indicative of HFpEF. CLINICAL TRIAL REGISTRATION URL: http://www.clinicaltrials.gov. Unique identifier: NCT01418248.
Department of Cardiology Aarhus University Hospital Aarhus Denmark
Department of Cardiology Institute for Clinical and Experimental Medicine Prague Czech Republic
From the Division of Cardiovascular Diseases Department of Medicine Mayo Clinic Rochester MN
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15014020
- 003
- CZ-PrNML
- 005
- 20150424111747.0
- 007
- ta
- 008
- 150420s2015 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1161/CIRCHEARTFAILURE.114.001731 $2 doi
- 035 __
- $a (PubMed)25342738
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Andersen, Mads J $u From the Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic Rochester, MN (M.J.A., T.P.O., G.C.K., B.A.B.); Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark (M.J.A.); and Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic (V.M.). $7 gn_A_00006086
- 245 10
- $a Differential hemodynamic effects of exercise and volume expansion in people with and without heart failure / $c MJ. Andersen, TP. Olson, V. Melenovsky, GC. Kane, BA. Borlaug,
- 520 9_
- $a BACKGROUND: Invasive hemodynamic exercise testing is commonly used in the evaluation of patients with suspected heart failure with preserved ejection fraction (HFpEF) or pulmonary hypertension. Saline loading has been suggested as an alternative provocative maneuver, but the hemodynamic changes induced by the 2 stresses have not been compared. METHODS AND RESULTS: Twenty-six subjects (aged, 67±10 years; n=14 HFpEF; n=12 control) underwent right heart catheterization at rest, during supine exercise, and with acute saline loading in a prospective study. Exercise and saline each increased cardiac output and pressures in the right atrium, pulmonary artery, and pulmonary capillary wedge positions. Changes in heart rate, blood pressure, rate-pressure product, and cardiac output were greater with exercise compared with saline. In controls subjects, right atrial pressure, pulmonary arterial pressure, and pulmonary capillary wedge pressure increased similarly with saline and exercise, whereas in HFpEF subjects, exercise led to ≈2-fold greater increases in right atrial pressure (10±4 versus 6±3 mm Hg; P=0.02), pulmonary arterial pressure (22±8 versus 11±4 mm Hg; P=0.0001), and pulmonary capillary wedge pressure (18±5 versus 10±4 mm Hg; P<0.0001) compared with saline. Systolic reserve assessed by stroke work and cardiac power output was lower in HFpEF subjects with both exercise and saline. Systemic and pulmonary arterial compliances were enhanced with saline but reduced with exercise. CONCLUSIONS: Exercise elicits greater pulmonary capillary wedge pressure elevation compared with saline in HFpEF but not controls, suggesting that hemodynamic stresses beyond passive stiffness and increased venous return explain the development of pulmonary venous hypertension in HFpEF. Exercise testing is more sensitive than saline loading to detect hemodynamic derangements indicative of HFpEF. CLINICAL TRIAL REGISTRATION URL: http://www.clinicaltrials.gov. Unique identifier: NCT01418248.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a srdeční katetrizace $7 D006328
- 650 _2
- $a cvičení $x fyziologie $7 D015444
- 650 _2
- $a terapie cvičením $x metody $7 D005081
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a následné studie $7 D005500
- 650 _2
- $a srdeční selhání $x patofyziologie $x terapie $7 D006333
- 650 _2
- $a hemodynamika $x fyziologie $7 D006439
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a intravenózní infuze $7 D007262
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a chlorid sodný $x aplikace a dávkování $x diagnostické užití $7 D012965
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a randomizované kontrolované studie $7 D016449
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Olson, Thomas P $u From the Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic Rochester, MN (M.J.A., T.P.O., G.C.K., B.A.B.); Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark (M.J.A.); and Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic (V.M.).
- 700 1_
- $a Melenovsky, Vojtech $u From the Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic Rochester, MN (M.J.A., T.P.O., G.C.K., B.A.B.); Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark (M.J.A.); and Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic (V.M.).
- 700 1_
- $a Kane, Garvan C $u From the Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic Rochester, MN (M.J.A., T.P.O., G.C.K., B.A.B.); Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark (M.J.A.); and Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic (V.M.).
- 700 1_
- $a Borlaug, Barry A $u From the Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic Rochester, MN (M.J.A., T.P.O., G.C.K., B.A.B.); Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark (M.J.A.); and Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic (V.M.). borlaug.barry@mayo.edu.
- 773 0_
- $w MED00159985 $t Circulation. Heart failure. Heart failure $x 1941-3297 $g Roč. 8, č. 1 (2015), s. 41-8
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25342738 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150420 $b ABA008
- 991 __
- $a 20150424112047 $b ABA008
- 999 __
- $a ok $b bmc $g 1071601 $s 896898
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 8 $c 1 $d 41-8 $i 1941-3297 $m Circulation. Heart failure $n Circ Heart Fail $x MED00159985 $o Heart failure
- LZP __
- $a Pubmed-20150420